Literature DB >> 20031459

Field strength dependence of PRESS timings for simultaneous detection of glutamate and glutamine from 1.5 to 7T.

Jeff Snyder1, Alan Wilman.   

Abstract

An optimization of the PRESS sequence for magnetic resonance spectroscopy is presented to simultaneously detect the important brain metabolites of glutamate (Glu) and glutamine (Gln) at field strengths of 1.5, 3, 4.7, and 7T. Standard, clinical examinations typically use short echo times which in general are not ideal for the separation of Glu and Gln. The optimization procedure is based on numerical product operator simulations to produce yield and overlap measurements for all possible practical choices of PRESS inter-echo timings. The simulations illustrate the substantial modulations in Glu and Gln with field strength. At all field strengths, the optimized timings demonstrate a significant reduction in overlap compared to short echo PRESS, while maintaining a high metabolite signal, with Glu and Gln yields >90% when excluding T2 relaxation losses. Minimal overlap was attained at 7T (0.3% Gln contamination in the Glu signal), and 4.7T (1.2%). The optimized timings were applied in vivo on healthy volunteers at field strengths of 1.5 and 4.7T. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031459     DOI: 10.1016/j.jmr.2009.12.002

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  21 in total

Review 1.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

2.  Regional distributions of brain glutamate and glutamine in normal subjects.

Authors:  Mohammed Z Goryawala; Sulaiman Sheriff; Andrew A Maudsley
Journal:  NMR Biomed       Date:  2016-06-28       Impact factor: 4.044

Review 3.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

4.  Monte Carlo study of metabolite correlations originating from spectral overlap.

Authors:  Sungtak Hong; Li An; Jun Shen
Journal:  J Magn Reson       Date:  2022-06-15       Impact factor: 2.734

5.  Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis.

Authors:  Shima Shakory; Jeremy J Watts; Sina Hafizi; Tania Da Silva; Saad Khan; Michael Kiang; R Michael Bagby; Sofia Chavez; Romina Mizrahi
Journal:  Neuropsychopharmacology       Date:  2018-07-28       Impact factor: 7.853

6.  Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.

Authors:  Elias Mouchlianitis; Michael A P Bloomfield; Vincent Law; Katherine Beck; Sudhakar Selvaraj; Naresh Rasquinha; Adam Waldman; Federico E Turkheimer; Alice Egerton; James Stone; Oliver D Howes
Journal:  Schizophr Bull       Date:  2015-12-17       Impact factor: 9.306

Review 7.  Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.

Authors:  Tomomi Nakahara; Sakiko Tsugawa; Yoshihiro Noda; Fumihiko Ueno; Shiori Honda; Megumi Kinjo; Hikari Segawa; Nobuaki Hondo; Yukino Mori; Honoka Watanabe; Kazuho Nakahara; Kazunari Yoshida; Masataka Wada; Ryosuke Tarumi; Yusuke Iwata; Eric Plitman; Sho Moriguchi; Camilo de la Fuente-Sandoval; Hiroyuki Uchida; Masaru Mimura; Ariel Graff-Guerrero; Shinichiro Nakajima
Journal:  Mol Psychiatry       Date:  2021-09-28       Impact factor: 15.992

8.  Neuroanatomical changes in people with high schizotypy: relationship to glutamate levels.

Authors:  Gemma Modinos; Alice Egerton; Anna McLaughlin; Katrina McMullen; Veena Kumari; David J Lythgoe; Gareth J Barker; André Aleman; Steve C R Williams
Journal:  Psychol Med       Date:  2017-12-04       Impact factor: 7.723

9.  Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study.

Authors:  Zhengchao Dong; Michael F Grunebaum; Martin J Lan; Vashti Wagner; Tse-Hwei Choo; Matthew S Milak; Tarek Sobeih; J John Mann; Joshua T Kantrowitz
Journal:  Front Psychiatry       Date:  2021-06-02       Impact factor: 4.157

10.  Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis.

Authors:  Alice Egerton; James M Stone; Christopher A Chaddock; Gareth J Barker; Ilaria Bonoldi; Rachel M Howard; Kate Merritt; Paul Allen; Oliver D Howes; Robin M Murray; Mary A McLean; David J Lythgoe; Ruth L O'Gorman; Philip K McGuire
Journal:  Neuropsychopharmacology       Date:  2014-06-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.